COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 1183: Articles 11821-11830  | Next

Immunity to COVID-19 in India through vaccination and natural infection
Sarraf, T. R., Maity, S., Ghosh, A., Bhattacharjee, S., Pani, A., Saha, K., Chattopadhyay, D., Ghosh, G., Sen, M.
10.1101/2021.11.08.21266055 — Posted: 2021-11-09
The effects of the first national lockdown in England on geographical inequalities in the evolution of COVID-19 case rates: An ecological study
Welsh, C. E., Albani, V., Matthews, F. E., Bambra, C.
10.1101/2021.11.09.21266122 — Posted: 2021-11-09
SARS-CoV-2 triggered excessive inflammation and abnormal energy metabolism in gut microbiota
Zhou, T.
10.1101/2021.11.08.467715 — Posted: 2021-11-09
The preparedness and response to COVID-19 in a quaternary Intensive Care Unit in Australia: perspectives and insights from frontline critical care clinicians
SUNDARARAJAN, K., Bi, P., Milazzo, A., Poole, A., Reddi, B., Mahmood, A.
10.1101/2021.11.05.21265998 — Posted: 2021-11-09
The effect of notification window length on the epidemiological impact of COVID-19 contact tracing mobile applications
Leng, T., Hill, E. M., Keeling, M. J., Tildesley, M. J., Thompson, R. N.
10.1101/2021.11.08.21266079 — Posted: 2021-11-09
Regional and temporal variations affect the accuracy of variant-specific SARS-CoV-2 PCR assays
Oh, C., Sashittal, P., Zhou, A., Wang, L., El-Kebir, M., Nguyen, T. H.
10.1101/2021.11.08.21266083 — Posted: 2021-11-09
Patient trajectories among hospitalised COVID-19 patients vaccinated with an mRNA vaccine in Norway: a register-based cohort study
Whittaker, R., Brathen Kristofferson, A., Valcarcel Salamanca, B., Seppala, E., Golestani, K., Kvale, R., Watle, S., Buanes, E.
10.1101/2021.11.05.21265958 — Posted: 2021-11-09 Discussion: Onsite
Safety Assessment of BNT162b2 Vaccine in Adolescents Aged 12-15 Years
Patel, J., Bhavsar, B., Parikh, S., Ladani, N.
10.1101/2021.11.06.21266016 — Posted: 2021-11-09
Compassionate Use of REGEN-COV(R) in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders
Stein, D., Oviedo-Orta, E., Kampman, W. A., McGinniss, J., Betts, G., McDermott, M., Holly, B., Lancaster, J. M., Braunstein, N., Yancopoulos, G. D., Weinreich, D. M.
10.1101/2021.11.05.21265911 — Posted: 2021-11-09
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report
Gandhi, S., Klein, J., Robertson, A., Pena-Hernandez, M. A., Lin, M. J., Roychoudhury, P., Lu, P., Fournier, J., Ferguson, D., Mohamed Bakhash, S. A., Muenker, M. C., Srivathsan, A., Wunder, E. A., Kerantzas, N., Wang, W., Pyle, A., Wilen, C. B., Ogbuagu, O., Greninger, A. L., Iwasaki, A., Schulz, W. L., Ko, A. I.
10.1101/2021.11.08.21266069 — Posted: 2021-11-09 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).